{
    "clinical_study": {
        "@rank": "107733", 
        "acronym": "ACTISUCROSE", 
        "arm_group": [
            {
                "arm_group_label": "saccharose", 
                "arm_group_type": "Experimental", 
                "description": "20% saccharose"
            }, 
            {
                "arm_group_label": "breast-feeding", 
                "arm_group_type": "Placebo Comparator", 
                "description": "breast-feeding"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to compare the impact of two non-medicinal strategies: the\n      breast-feeding and saccharose to measure effects in cerebral cortex during pain using near\n      infrared spectroscopy (NIRS)"
        }, 
        "brief_title": "Prevention of the Procedural Pain in the Newborn", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Prevention of the Procedural Pain in the Newborn", 
        "detailed_description": {
            "textblock": "Many studies of non-medicinal treatments(saccharose and breast-feeding)show a decrease of\n      expression of pain in newborn. However Slater and al questioned these practices due to the\n      absence of modification of the cerebral answer measured by evoked potential."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gestationnel age included between 37 and 42 weeks\n\n          -  Born in the CHRU of Brest\n\n          -  Breast-Fed\n\n          -  Score of Apgar upper to 7\n\n          -  No pathology malformative\n\n          -  Absence of known chromosomal abnormality\n\n          -  Consent of parents\n\n        Exclusion Criteria:\n\n          -  Maternal drug use\n\n          -  Morphinic treatment\n\n          -  Barbiturate treatment\n\n          -  Benzodiaz\u00e9pine treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "42 Weeks", 
            "minimum_age": "37 Weeks"
        }, 
        "enrollment": {
            "#text": "114", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02109263", 
            "org_study_id": "RB 12.143"
        }, 
        "intervention": {
            "arm_group_label": [
                "saccharose", 
                "breast-feeding"
            ], 
            "description": "saccharose versus breast-feeding", 
            "intervention_name": "saccharose versus breast-feeding", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast-feeding", 
            "Saccharose", 
            "Breast-feeding newborn", 
            "cortical pain responses", 
            "near infrared spectroscopy (NIRS)", 
            "Salivary rate cortisol", 
            "heel lance"
        ], 
        "lastchanged_date": "April 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Brest", 
                    "country": "France", 
                    "zip": "29200"
                }, 
                "name": "Centre hospitalier universitaire"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Breastfeeding Versus Saccharose for Prevention of the Procedural Pain in the Newborn", 
        "overall_official": {
            "affiliation": "Pole de la femme, de la M\u00e8re et de l'Enfant, CHRU de Brest", 
            "last_name": "Jean-Michel ROUE", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Increase of the total concentration of haemoglobin (delta HbT) measured by the spectrometer during the intravenous injection.", 
            "measure": "Increase of the total concentration of haemoglobin", 
            "safety_issue": "No", 
            "time_frame": "Measure two minutes before painful gesture, at the moment of painful gesture and 2 minutes after painful gesture. The newborn will be followed for the duration of hospital stay, an expected average of 30 to 60 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02109263"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Salivary cortisol sampling", 
            "measure": "Dosage of rate salivary cortisol", 
            "safety_issue": "No", 
            "time_frame": "before and after painful gesture"
        }, 
        "source": "University Hospital, Brest", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Brest", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}